Reset filters
  • 14 July 2004

Pilot study finds weekend breaks from HAART may be possible on NNRTIs

Read the article
  • 13 July 2004

Could monotherapy with Kaletra become an option for HIV treatment?

Read the article
  • 13 July 2004

IAS issue updated HIV treatment guidelines for rich countries

Read the article
  • 13 July 2004

Abstinence debate finds more consensus than difference

Read the article
  • 13 July 2004

Initiating HAART with any one of four 3 x 5 drug choices leads to longest survival in San Francisco

Read the article
  • 13 July 2004

Two-year data continue to show promise for T-20

Read the article
  • 12 July 2004

Once daily Reverset safe and effective over ten days in treatment-naïve and –experienced patients

Read the article
  • 12 July 2004

Tenofovir has viral potency, a good lipid and safety profile, and should be available for first line HAART says study

Read the article
  • 12 July 2004

Efavirenz can be used at normal dose with rifampicin, Thais report

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.